1. Home
  2. SHEN vs FULC Comparison

SHEN vs FULC Comparison

Compare SHEN & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shenandoah Telecommunications Co

SHEN

Shenandoah Telecommunications Co

HOLD

Current Price

$14.00

Market Cap

803.5M

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$6.89

Market Cap

718.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEN
FULC
Founded
1902
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
803.5M
718.4M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
SHEN
FULC
Price
$14.00
$6.89
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$26.00
$16.38
AVG Volume (30 Days)
229.2K
1.2M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
0.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$357,854,000.00
N/A
Revenue This Year
$6.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.08
N/A
52 Week Low
$9.67
$2.32
52 Week High
$15.92
$15.74

Technical Indicators

Market Signals
Indicator
SHEN
FULC
Relative Strength Index (RSI) 50.57 29.67
Support Level $13.97 $6.33
Resistance Level $15.86 $7.28
Average True Range (ATR) 0.62 0.47
MACD -0.15 -0.06
Stochastic Oscillator 26.36 10.38

Price Performance

Historical Comparison
SHEN
FULC

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Share on Social Networks: